AG
BSX icon

Aperio Group’s Boston Scientific BSX Stock Holding History

Aperio Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$23.3M Sell
648,532
-100,286
-13% -$3.61M 0.07% 277
2020
Q3 		$28.6M Buy
748,818
+25,716
+4% +$991K 0.1% 200
2020
Q2 		$25.4M Buy
723,102
+13,103
+2% +$472K 0.09% 212
2020
Q1 		$23.2M Sell
709,999
-66,805
-9% -$2.61M 0.1% 204
2019
Q4 		$35.1M Sell
776,804
-7,745
-1% -$324K 0.13% 181
2019
Q3 		$31.9M Buy
784,549
+13,506
+2% +$572K 0.13% 185
2019
Q2 		$33.1M Buy
771,043
+18,861
+3% +$725K 0.14% 166
2019
Q1 		$28.9M Buy
752,182
+41,384
+6% +$1.58M 0.12% 180
2018
Q4 		$25.1M Buy
710,798
+49,134
+7% +$1.78M 0.13% 182
2018
Q3 		$25.5M Buy
661,664
+14,068
+2% +$491K 0.11% 202
2018
Q2 		$21.2M Buy
647,596
+74,481
+13% +$2.25M 0.1% 225
2018
Q1 		$15.7M Buy
573,115
+53,708
+10% +$1.46M 0.08% 301
2017
Q4 		$12.9M Buy
519,407
+2,830
+0.5% +$78.1K 0.07% 349
2017
Q3 		$15.1M Buy
516,577
+57,485
+13% +$1.59M 0.09% 280
2017
Q2 		$12.7M Buy
459,092
+45,335
+11% +$1.2M 0.08% 304
2017
Q1 		$10.3M Buy
413,757
+32,405
+8% +$788K 0.07% 335
2016
Q4 		$8.25M Sell
381,352
-54,069
-12% -$1.18M 0.06% 359
2016
Q3 		$10.4M Buy
435,421
+31,151
+8% +$743K 0.08% 306
2016
Q2 		$9.45M Buy
404,270
+38,322
+10% +$829K 0.07% 311
2016
Q1 		$6.88M Buy
365,948
+56,127
+18% +$986K 0.06% 372
2015
Q4 		$5.71M Buy
309,821
+31,265
+11% +$560K 0.05% 418
2015
Q3 		$4.57M Buy
278,556
+36,084
+15% +$617K 0.05% 451
2015
Q2 		$4.29M Buy
242,472
+36,335
+18% +$649K 0.04% 462
2015
Q1 		$3.66M Buy
206,137
+25,160
+14% +$398K 0.04% 493
2014
Q4 		$2.4M Buy
180,977
+3,591
+2% +$45.9K 0.03% 587
2014
Q3 		$2.1M Sell
177,386
-7,108
-4% -$89.5K 0.03% 599
2014
Q2 		$2.36M Buy
184,494
+13,637
+8% +$177K 0.03% 547
2014
Q1 		$2.31M Buy
+170,857
New +$2.24M 0.03% 657
2013
Q4 		– Sell
-142,334
Closed -$1.68M – 677
2013
Q3 		$1.67M Buy
142,334
+36,589
+35% +$396K 0.03% 652
2013
Q2 		$980K Buy
+105,745
New +$897K 0.02% 765

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Aperio Group's BSX Position: Q4 2020 in Review

Aperio Group reduced its Boston Scientific (BSX) stake by 13% in Q4 2020, selling an estimated $3.61M and leaving 648,532 shares worth $23.3M. The position accounts for 0.07% of the portfolio, ranked #277.

Aperio Group first reported a position in BSX in Q2 2013 and has held it in 30 quarters since. The position peaked at $35.1M in Q4 2019. 864 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • Aperio Group held 648,532 shares of Boston Scientific worth $23.3M as of Q4 2020.
  • Aperio Group sold 100,286 Boston Scientific shares in Q4 2020, an estimated $3.61M.
  • Boston Scientific made up 0.07% of Aperio Group's portfolio in Q4 2020, its #277 holding.
  • Aperio Group first reported a position in Boston Scientific in Q2 2013 and has held it in 30 quarters since.
  • Aperio Group's Boston Scientific position peaked at $35.1M in Q4 2019.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.